ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Porphyria, Acute Intermittent

  • A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)
  • ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
  • A Study to Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)
  • Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
  • Acute Porphyria Biomarkers for Disease Activity
  • A Phase 1 Study of Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP)
  • Porphozym in the Treatment of Acute Attacks in AIP
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group